Rubric condition met: D, no direction: animal and mechanistic evidence only; preclinical data cannot carry a direction
Sleep-promoting effects come from brain-injection studies of synthetic N3-substituted uridine derivatives in mice and rats and receptor-binding work, summarized in a 2001 review that describes the uridine receptor as not yet characterized; the direction rests on these derivatives, not on oral uridine or UMP. No controlled trial of uridine on sleep in adults was found (PubMed and Europe PMC, November 11, 2026); the PubMed search also returned one infant cereal trial of a multi-ingredient product, which does not test uridine. Re-appraised November 14, 2026: the only support is a review of rodent work with synthetic N3-substituted uridine derivatives, partly by injection. Preclinical evidence cannot carry an effect direction.
How sure are we?
Evidence maturity: Mechanistic only Rodent brain-injection studies of synthetic N3-substituted uridine derivatives and receptor work only; preclinical evidence cannot carry an effect direction.
Uridine receptor: discovery and its involvement in sleep mechanism.
Kimura T, Ho IK, Yamamoto I. Uridine receptor: discovery and its involvement in sleep mechanism Sleep, 2001. PMID 11322706
Result not recorded
Design
Narrative review of animal and receptor-binding studies
Population
Mice and rats; bovine brain membranes
Funding
not stated
Search and history
Search (): uridine[ti] AND sleep[tiab]
Graded D (awaiting approval)
D to D (awaiting approval): Preclinical evidence cannot carry an effect direction.
D to D (awaiting approval) (maturity: mechanistic only): Maturity, bias summary and re-check date added
D to D (approved) (maturity: mechanistic only): Editor sign-off November 16, 2026: grade matches the editor-approved final page
A, strong: what grade A means
At least one meta-analysis or three independent randomized trials in the relevant healthy population, pointing the same way, with low or some risk of bias, at doses legally available.